We are live on ! Find out more
SLGCW

SomaLogic Warrant

Delisted

SLGCW was delisted on the 5th of January, 2024.

25 hedge funds and large institutions have $3.07M invested in SomaLogic Warrant in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

485% more capital inflows, than outflows

Capital inflows: $194K | Capital outflows: $33.2K

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

0% more funds holding

Funds holding: 25 → 25 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

Holders
25
Holders Change
–
Holders Change %
0%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
2
Closed
2
Calls
$51​K
Puts
–
Net Calls
+$51​K
Net Calls Change
-⁠$139​K

SLGCW Hedge Fund Activity: Q4 2022 in Review

25 of the 6,245 institutional investors tracked by Wall St. Rank reported a position in SomaLogic Warrant (SLGCW) for Q4 2022, worth a combined $3.07M — up 4.4% from $2.94M a quarter earlier.

Fund positioning in SLGCW was balanced in Q4 2022: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 2 trimmed.

The largest buyer was LMR Partners, adding an estimated $57.4K. The largest seller was SONA Asset Management (US), exiting entirely with an estimated $21K sold.

  • 25 institutional investors held SomaLogic Warrant (SLGCW) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $3.07M of SomaLogic Warrant stock for Q4 2022, up 4.4% quarter-over-quarter.
  • 2 funds opened new SomaLogic Warrant positions in Q4 2022 and 2 closed out, a net change of 0 holders.
  • The largest SomaLogic Warrant buyer in Q4 2022 was LMR Partners, an estimated $57.4K added.
  • The largest SomaLogic Warrant seller in Q4 2022 was SONA Asset Management (US), an estimated $21K sold.

Based on aggregated 13F filings for Q4 2022.